THRX

Theravance, Inc. News Headlines

$26.47
*  
0.66
 negative 
2.43%
Get THRX Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN
1/7/2013 12:04:47 PM - GuruFocus

Glaxo's Influenza Vaccine Approved - Analyst Blog
12/24/2012 4:00:01 PM - Zacks.com

Glaxo/Amicus' Fabry Drug Disappoints - Analyst Blog
12/21/2012 1:14:01 PM - Zacks.com

Glaxo/THRX's COPD Candidate Advances - Analyst Blog
12/20/2012 10:50:01 AM - Zacks.com

Pipeline Progress at Theravance - Analyst Blog
12/5/2012 9:20:01 AM - Zacks.com

Glaxo Invests in Nigeria - Analyst Blog
11/28/2012 9:10:01 AM - Zacks.com

Glaxo to Expand in India - Analyst Blog
11/27/2012 3:45:01 PM - Zacks.com

Wednesday's Bio-Pharma Catalyst Trades And Watch List
11/21/2012 7:50:00 AM - Seeking Alpha

Glaxo's Promacta Label Expanded - Analyst Blog
11/20/2012 12:20:01 PM - Zacks.com

Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 Update
11/14/2012 4:57:00 AM - Seeking Alpha

Promising Biotech Stocks With Upcoming FDA Catalysts
11/13/2012 10:52:00 AM - Seeking Alpha

For NovaBay, Simplicity Is The Father Of Invention
11/12/2012 9:23:00 AM - Seeking Alpha

Theravance: Still A Buy On Weakness
11/4/2012 6:03:00 AM - Seeking Alpha

Glaxo Misses on Both Counts - Analyst Blog
11/1/2012 1:52:01 PM - Zacks.com

Loss at THRX Narrower Than Expected - Analyst Blog
10/31/2012 9:10:01 AM - Zacks.com

Theravance, Merck Ink Deal - Analyst Blog
10/18/2012 5:05:01 PM - Zacks.com

Amicus Therapeutics Could See A Move Like Sarepta On Positive Phase 3 Data
10/9/2012 7:50:00 AM - Seeking Alpha

Encouraging Data on Glaxo's Drug - Analyst Blog
10/8/2012 5:46:01 PM - Zacks.com

Theravance Stays Neutral - Analyst Blog
10/8/2012 5:24:01 PM - Zacks.com

Theravance, Alfa Wassermann Ink Deal - Analyst Blog
10/4/2012 5:35:01 PM - Zacks.com

Glaxo/THRX Drug Closer to Approval - Analyst Blog
9/27/2012 5:36:05 PM - Zacks.com

Glaxo Aims to Expand Synflorix Label - Analyst Blog
9/19/2012 11:34:52 AM - Zacks.com

Glaxo Increases Stake in RGDX - Analyst Blog
9/18/2012 5:35:01 PM - Zacks.com

Insider Buying Trends: Are These Cash-Rich Companies Ready For A Rally?
9/18/2012 2:13:00 PM - Seeking Alpha

5 Healthcare Stocks That Could Boost Your Portfolio By 2013
9/15/2012 1:40:00 AM - Seeking Alpha